Navigation Links
Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease
Date:11/30/2009

evaluation of the sensitivity and specificity of the visual assessment of regional tracer uptake in the florbetaben PET images compared to histological verification as well as the quantitative assessment of regional tracer uptake.

This worldwide study will be conducted at sites on four different continents. For information about enrolling in the study, please visit www.clinicaltrials.gov.

About Florbetaben (BAY 94-9172)

Florbetaben is an in-licensed 18F-labeled PET tracer that is currently being investigated for imaging of cerebral beta-Amyloid plaques. As the aggregation of the beta-Amyloid protein in the brain is also a key target for new therapeutic treatments under development for Alzheimer's disease, florbetaben might also be able to support the development of these new treatment approaches.

In the Phase II trial, florbetaben demonstrated potential to detect beta-Amyloid plaques in the brain as a pathological hallmark of disease in probable Alzheimer's disease patients. Twenty-nine adverse events (AEs) were reported in 24 subjects (18%) in the Phase II trial. Five subjects (two with probable Alzheimer's disease, three cognitively non-impaired healthy volunteers) had AEs deemed to be related to florbetaben. These included fatigue, "feeling hot", increased blood pressure, hematoma and "shaking of both hands." The most frequent AEs, regardless of relationship, were injection-site changes. All AEs in the trial were mild-to-moderate intensity and resolved during the study period.

Bayer has decided to extend the Phase II study and is currently recruiting patients in the United States, Germany, Japan, Australia and Switzerland.

Results of the Phase II study were presented at the International Conference on Alzheimer's diseases (ICAD) in Vienna, Austria in July 2009 and at the 19th World Congress of Neurology (WCN) in Bangkok, Tha
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Genzyme and Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of Multiple Sclerosis
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
4. Bayer HealthCare Celebrates 20th Anniversary of Kogenate(R) Product Line and 8 Billion IU Milestone at 2008 WFH World Congress
5. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
6. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
7. FDA Approves Bayer HealthCares Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A
8. Bayer Announces Upcoming Presentations of Campath(R) and Leukine(R) Data at the 50th Annual Meeting of the American Society of Hematology
9. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
10. Bayer Announces Leukine(R) Data Presentations at 45th American Society of Clinical Oncology (ASCO) Annual Meeting
11. Bayer Announces New Data on Novel Anti-cancer Compound BAY 73-4506
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 2014 In today,s rapidly changing, highly ... tools are essential for survival. The world is ... desires, preferences, and unmet needs are evolving rapidly. ... across all industries are continually searching for innovative ... adoption of new market research techniques like mobile ...
(Date:12/19/2014)... CARDIFF-BY-THE-SEA, Calif. , Dec. 19, ... SRNE ;  Sorrento), an oncology company developing new ... Inc., a privately-held immuno-oncology company developing proprietary Neukoplast ... based therapy, announced today that the companies have ... next generation CAR-TNK™ (pronounced as "Car-Tank") immunotherapies for ...
(Date:12/19/2014)... , Dec. 18, 2014 Somewhere between ... hearing health was forgotten. But Audicus , a ... hear better this new year. Hearing loss ... the aging population, though it is often unaddressed. Forty-eight ... four has a hearing aid, mainly due to price. ...
Breaking Medicine Technology:Study Uncovers New Tools and Techniques for Understanding Consumer Decision Making 2Sorrento and Conkwest Announce Exclusive Global Collaboration 2Sorrento and Conkwest Announce Exclusive Global Collaboration 3Sorrento and Conkwest Announce Exclusive Global Collaboration 4Sorrento and Conkwest Announce Exclusive Global Collaboration 5Audicus Will Help People Resolve to Hear Better in 2015 2
... IntraOp Medical Corporation   (OTC: IOPD) is pleased to  ... nullification case that IntraOp Medical had appealed, and have ... IOERT linear accelerator with "straight through" accelerator guide design ... IntraOp Medical,s European Patent EP 0 700 ...
... Feb. 1, 2012 A new skin cancer drug tested ... at the Virginia G. Piper Cancer Center at Scottsdale Healthcare ... Administration, a remarkable accomplishment in new drug development. ... administered for the first time in the world Jan. 23, ...
Cached Medicine Technology:IntraOp Medical wins Patent Defense Suit Protecting Their Intellectual Property 2IntraOp Medical wins Patent Defense Suit Protecting Their Intellectual Property 3FDA Approves New Skin Cancer Drug First Tested in Arizona by Scottsdale Healthcare and TGen 2FDA Approves New Skin Cancer Drug First Tested in Arizona by Scottsdale Healthcare and TGen 3
(Date:12/20/2014)... (PRWEB) December 20, 2014 Parker & ... technicians with years of experience in contractor services announces ... contractor services for the homeowners of Arizona. Parker and ... a professional contractor technicians that make customer service the ... in Phoenix Arizona and started with one service vehicle ...
(Date:12/19/2014)... It’s very easy to become overwhelmed with the holidays ... the wayside until Christmas and the New Year are over. ... that burning desire to just escape it all and get ... Telluride with a no-fuss, affordable package. Montrose Days Inn will ... and ensure that all accommodations are met. Plus, everyone has ...
(Date:12/19/2014)... 19, 2014 Energy Textiles is ... now available. Celliant, the world’s leading responsive textile, ... pillowcases. , There are a number of benefits ... increased oxygenation and balanced body temperature; which can ... pain relief; enhanced athletic performance; and overall wellness. ...
(Date:12/19/2014)... SuperCloset raises the bar once again, with ... offer indoor growers the most efficient and effective indoor ... Rooms with the award winning SuperRooms for ... room setup. , The SuperClone Room features the most ... 50 . The SuperClone Room pairs this ...
(Date:12/19/2014)... An evening dress is perfect for any occasion and ... distinguished dresses retailer, has unveiled its new selection of evening ... great shopping platform. Customers can view more at ... has been accepted and praised by customers for many years. ... for clients. In order to expand its market share, the ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 2Health News:Parker & Sons Announces Reaching A Milestone By Providing 40 Years Of Dedicated Contractor Services For Homeowners Of Arizona 3Health News:Days Inn Montrose Colorado Delivers Last Minute Holiday Season Ski Getaway Accommodations 2Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:SuperCloset Continues to Innovate with New Complete Indoor Grow Room Packages, The SuperClone Rooms are the Newest Addition to the Award Winning SuperRoom Lineup 2Health News:Attractive Evening Dresses Announced by Discount-Dress.com 2
... implications for stroke, Alzheimer,s disease , WEDNESDAY, May 26 (HealthDay ... vessels remove blood clots from the brain in mice -- ... of how to treat people who suffer from Alzheimer,s disease ... brain is crucial to allow blood to flow unimpeded, since ...
... N.Y. Rensselaer Polytechnic Institute Professor Richard Radke ... develop novel computer automation techniques that could reduce ... from several hours to a few minutes. ... is extremely effective for treating cancer. Pioneered by ...
... has dramatically increased survival in the small group of patients ... Their findings will be presented at the annual meeting of ... held June 4-8 in Chicago. Mayo oncologists say this ... when this rare cancer seems to be confined to the ...
... ... implants will have at least one broken implant within 11 years. Smart Choice ... MRI has become the first MRI clinic in Milwaukee to offer a silicone ... only $600, up to a 75% savings when compared to other MRI providers. ...
... ... Dispensing System™ at ASCP as one option for addressing health reform’s new medication waste ... ... has surpassed 500 customers of its world-class software and proven hardware components to enhance ...
... mice, researchers found , WEDNESDAY, May 26 (HealthDay News) ... certain industrial chemicals while pregnant are at an increased ... animal study suggests. , The chemicals -- bisphenol-A (BPA) ... manufacturing purposes, and are known for interfering with hormonal ...
Cached Medicine News:Health News:Brain Cells May Serve as Clot-Busters 2Health News:Rensselaer researcher wins $1.4 million NIH grant to enable faster cancer treatment planning 2Health News:New treatment approach to rare cancer results in prolonged survival 2Health News:Affordable Implant Screening: Protect Against "Silent" Ruptures 2Health News:Talyst Reaches Major Milestone: 500 Implementations in Long-Term Care, Acute Care and Corrections 2Health News:Talyst Reaches Major Milestone: 500 Implementations in Long-Term Care, Acute Care and Corrections 3Health News:Prenatal Exposure to Chemicals Linked to Breast Cancer Risk 2
... MOST Options System is designed to ... of the knee or hip to ... provides the potential for restoration of ... the requirements of a rotating hinge ...
... System (OSS) from Biomet Inc. offers ... designed specifically for orthopaedic surgeons and ... in their patients: significant bone loss, ... revision arthroplasties, and multiple hip revision ...
... Surgical Helmet System from DePuy offers a ... system helps meet OSHA recommendations regarding occupational ... creating a new standard for comfort. ... offer unequaled comfort, featuring a lightweight, hose-free, ...
DePuy's Shoe Boots are sealed thermoplastic boots that help provide splash protection from microorganisms, particulate matter and body fluids....
Medicine Products: